
AstraZeneca PLC AZN
Quarterly report 2025-Q4
added 05-14-2026
AstraZeneca PLC DIO Ratio 2011-2026 | AZN
Annual DIO Ratio AstraZeneca PLC
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | 206 | 168 | 122 | 132 | 139 | 112 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 206 | 112 | 147 |
DIO Ratio of other stocks in the Biotechnology industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
FSD Pharma
HUGE
|
174 | - | 5743.5 % | $ 69.7 M | ||
|
Happiness Biotech Group Limited
HAPP
|
1.91 K | - | 1.35 % | $ 17.8 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
512 | - | - | $ 40.3 B | ||
|
Coherus BioSciences
CHRS
|
97.5 | $ 1.63 | -4.4 % | $ 191 M | ||
|
Esperion Therapeutics
ESPR
|
2.46 K | $ 3.12 | - | $ 649 M | ||
|
Exelixis
EXEL
|
96.1 | $ 51.1 | -0.37 % | $ 13.9 B | ||
|
Karyopharm Therapeutics
KPTI
|
52.5 | $ 8.9 | 0.56 % | $ 1.08 M | ||
|
Midatech Pharma plc
MTP
|
40.6 | - | -18.52 % | $ 27.3 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
166 | $ 17.3 | -5.57 % | $ 809 M | ||
|
Институт стволовых клеток человека
ISKJ
|
275 | - | - | - | ||
|
Gilead Sciences
GILD
|
102 | $ 132.06 | -0.74 % | $ 164 B | ||
|
Aeterna Zentaris
AEZS
|
55.6 | - | 5.93 % | $ 314 M | ||
|
Grifols, S.A.
GRFS
|
0.000171 | $ 7.79 | 1.04 % | $ 5.29 B | ||
|
Fortress Biotech
FBIO
|
210 | $ 2.3 | 3.14 % | $ 64.2 M | ||
|
Albireo Pharma
ALBO
|
26.1 | - | -0.23 % | $ 916 M | ||
|
Arcutis Biotherapeutics
ARQT
|
185 | $ 21.57 | -0.55 % | $ 2.74 B |